ZENOTECH LABORATORIES Financial Statement Analysis
|
||
The Revenues of ZENOTECH LABORATORIES have increased by 16.02% YoY .
The Earnings Per Share (EPS) of ZENOTECH LABORATORIES has decreased by -28.42 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
ZENOTECH LABORATORIES Last 5 Annual Financial Results
[BOM: 532039]
Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹42 Cr | ₹37 Cr | ₹22 Cr | ₹26 Cr | ₹13 Cr |
Expenses | ₹22 Cr | ₹19 Cr | ₹16 Cr | ₹17 Cr | ₹17 Cr |
Operating Profit (Excl OI) | ₹21 Cr | ₹17 Cr | ₹6.38 Cr | ₹8.98 Cr | ₹-3.52 Cr |
Other Income | ₹1.08 Cr | ₹0.63 Cr | ₹0.41 Cr | ₹1.17 Cr | ₹4.71 Cr |
Interest | ₹0.11 Cr | ₹1.22 Cr | ₹1.55 Cr | ₹0.89 Cr | ₹0.12 Cr |
Depreciation | ₹7.17 Cr | ₹6.97 Cr | ₹6.46 Cr | ₹4.85 Cr | ₹4.20 Cr |
Profit Before Tax | ₹15 Cr | ₹9.90 Cr | ₹-1.22 Cr | ₹11 Cr | ₹-3.13 Cr |
Profit After Tax | ₹12 Cr | ₹22 Cr | ₹-1.22 Cr | ₹11 Cr | ₹-3.13 Cr |
Earnings Per Share (Rs) | ₹1.36 | ₹1.90 | ₹3.63 | ₹-0.20 | ₹1.77 |
PAT Margin (%) | 20.32 | 27.31 | 60.65 | -5.41 | 41.42 |
ROE(%) | 9.60 | 15.15 | 37.26 | -2.48 | 24.35 |
ROCE(%) | 12.89 | 18.39 | 15.26 | 0.48 | 18.32 |
Total Debt/Equity(x) | 0.00 | 0.00 | 0.08 | 0.43 | 0.38 |
Key Financials |
||
Market Cap | : | ₹ 431.3 Cr |
Revenue (TTM) | : | ₹ 39.7 Cr |
Net Profit(TTM) | : | ₹ 6.7 Cr |
EPS (TTM) | : | ₹ 1.1 |
P/E (TTM) | : | 64.8 |
Industry Peers & Returns | 1W | 1M | 1Y |
ZENOTECH LABORATORIES | -0.6% | -7% | 8% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | 4.6% | 47.5% |
CIPLA | -1.1% | -0.3% | 20.7% |
DR REDDYS LABORATORIES | 2.2% | 12.1% | 21.6% |
ZYDUS LIFESCIENCES | -2.7% | 0.8% | 43.8% |
DIVIS LABORATORIES | 1% | -3.2% | 59.3% |
MANKIND PHARMA | 0.8% | 12.8% | 52.4% |
TORRENT PHARMACEUTICALS | -1.5% | 5.9% | 55% |
LUPIN | 0.9% | 7.2% | 72.7% |
ZENOTECH LABORATORIES Revenues
[BOM: 532039]
Y-o-Y | 16.02 % |
5 Yr CAGR | 34.33 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹42 Cr | 16.02 | |
Mar2023 | ₹37 Cr | 62.91 | |
Mar2022 | ₹22 Cr | -13.74 | |
Mar2021 | ₹26 Cr | 99.72 | |
Mar2020 | ₹13 Cr | - |
ZENOTECH LABORATORIES Operating Profit
[BOM: 532039]
Y-o-Y | 18.57 % |
5 Yr CAGR | Positive |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹21 Cr | 18.57 | |
Mar2023 | ₹17 Cr | 173.68 | |
Mar2022 | ₹6.38 Cr | -28.95 | |
Mar2021 | ₹8.98 Cr | Positive | |
Mar2020 | ₹-3.52 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 2.20 % |
5 Yr CAGR | Positive |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 48.8% | 2.20 | |
Mar2023 | 47.75% | 67.96 | |
Mar2022 | 28.43% | -17.62 | |
Mar2021 | 34.51% | Positive | |
Mar2020 | -26.99% | - |
ZENOTECH LABORATORIES Profit After Tax
[BOM: 532039]
Y-o-Y | -47.76 % |
5 Yr CAGR | Positive |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹12 Cr | -47.76 | |
Mar2023 | ₹22 Cr | Positive | |
Mar2022 | ₹-1.22 Cr | Negative | |
Mar2021 | ₹11 Cr | Positive | |
Mar2020 | ₹-3.13 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -25.60 % |
5 Yr CAGR | -16.31 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 20.32 % | -25.60 | |
Mar2023 | 27.31 % | -54.97 | |
Mar2022 | 60.65 % | Positive | |
Mar2021 | -5.41 % | Negative | |
Mar2020 | 41.42 % | - |
ZENOTECH LABORATORIES Earnings Per Share (EPS)
[BOM: 532039]
Y-o-Y | -28.42 % |
5 Yr CAGR | -6.38 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹1.36 | -28.42 | |
Mar2023 | ₹1.90 | -47.66 | |
Mar2022 | ₹3.63 | Positive | |
Mar2021 | ₹-0.20 | Negative | |
Mar2020 | ₹1.77 | - |
ZENOTECH LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532039]
Y-o-Y | -29.91 % |
5 Yr CAGR | -8.41 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 12.89% | -29.91 | |
Mar2023 | 18.39% | 20.51 | |
Mar2022 | 15.26% | 3,079.17 | |
Mar2021 | 0.48% | -97.38 | |
Mar2020 | 18.32% | - |
ZENOTECH LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹70.7 |
Current MarketCap | : | ₹ 431.3 Cr |
Updated EOD on | : | Dec 26,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZENOTECH LABORATORIES | -0.6% |
-7% |
8% |
SENSEX | -2.1% |
-2% |
11.3% |
ZENOTECH LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about ZENOTECH LABORATORIES Financials
How the annual revenues of ZENOTECH LABORATORIES have changed ?
The Revenues of ZENOTECH LABORATORIES have increased by 16.02% YoY .
How the Earnings per Share (EPS) of ZENOTECH LABORATORIES have changed?
The Earnings Per Share (EPS) of ZENOTECH LABORATORIES has decreased by -28.42 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs